{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T10:15:02Z","timestamp":1784542502698,"version":"3.55.0"},"reference-count":50,"publisher":"American Association for Cancer Research (AACR)","issue":"18","license":[{"start":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T00:00:00Z","timestamp":1663200000000},"content-version":"vor","delay-in-days":58,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>PNOC003 is a multicenter precision medicine trial for children and young adults with newly diagnosed diffuse intrinsic pontine glioma (DIPG).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods:<\/jats:title>\n                    <jats:p>Patients (3\u201325 years) were enrolled on the basis of imaging consistent with DIPG. Biopsy tissue was collected for whole-exome and mRNA sequencing. After radiotherapy (RT), patients were assigned up to four FDA-approved drugs based on molecular tumor board recommendations. H3K27M-mutant circulating tumor DNA (ctDNA) was longitudinally measured. Tumor tissue and matched primary cell lines were characterized using whole-genome sequencing and DNA methylation profiling. When applicable, results were verified in an independent cohort from the Children's Brain Tumor Network (CBTN).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Of 38 patients enrolled, 28 patients (median 6 years, 10 females) were reviewed by the molecular tumor board. Of those, 19 followed treatment recommendations. Median overall survival (OS) was 13.1 months [95% confidence interval (CI), 11.2\u201318.4] with no difference between patients who followed recommendations and those who did not. H3K27M-mutant ctDNA was detected at baseline in 60% of cases tested and associated with response to RT and survival. Eleven cell lines were established, showing 100% fidelity of key somatic driver gene alterations in the primary tumor. In H3K27-altered DIPGs, TP53 mutations were associated with worse OS (TP53mut 11.1 mo; 95% CI, 8.7\u201314; TP53wt 13.3 mo; 95% CI, 11.8\u2013NA; P = 3.4e\u22122), genome instability (P = 3.1e\u22123), and RT resistance (P = 6.4e\u22124). The CBTN cohort confirmed an association between TP53 mutation status, genome instability, and clinical outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Upfront treatment-na\u00efve biopsy provides insight into clinically relevant molecular alterations and prognostic biomarkers for H3K27-altered DIPGs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/1078-0432.ccr-22-0803","type":"journal-article","created":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T11:15:37Z","timestamp":1658229337000},"page":"3965-3978","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003"],"prefix":"10.1158","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7765-7690","authenticated-orcid":false,"given":"Cassie","family":"Kline","sequence":"first","affiliation":[{"name":"1Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5914-9083","authenticated-orcid":false,"given":"Payal","family":"Jain","sequence":"additional","affiliation":[{"name":"2Division of Neurosurgery, Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1478-3619","authenticated-orcid":false,"given":"Lindsay","family":"Kilburn","sequence":"additional","affiliation":[{"name":"3Department of Hematology and Oncology, Children's National Hospital, Washington, DC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3889-2759","authenticated-orcid":false,"given":"Erin R.","family":"Bonner","sequence":"additional","affiliation":[{"name":"4Center for Genetic Medicine Research, Children's National Hospital, Washington, DC."},{"name":"5Institute for Biomedical Sciences, The George Washington University School of Medicine and Health Sciences, Washington, DC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9539-7052","authenticated-orcid":false,"given":"Nalin","family":"Gupta","sequence":"additional","affiliation":[{"name":"6Department of Neurological Surgery, University of California, San Francisco, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4100-7001","authenticated-orcid":false,"given":"John R.","family":"Crawford","sequence":"additional","affiliation":[{"name":"7Department of Neuroscience, University of California, San Diego, California."},{"name":"8Rady Children's Hospital San Diego, San Diego, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1694-4319","authenticated-orcid":false,"given":"Anu","family":"Banerjee","sequence":"additional","affiliation":[{"name":"6Department of Neurological Surgery, University of California, San Francisco, California."},{"name":"9Department of Pediatrics, University of California, San Francisco, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger J.","family":"Packer","sequence":"additional","affiliation":[{"name":"10Center for Neuroscience and Behavioral Medicine, Children's National Hospital, Washington, DC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5910-0757","authenticated-orcid":false,"given":"Javier","family":"Villanueva-Meyer","sequence":"additional","affiliation":[{"name":"11Department of Radiology and Biomedical Imaging, University of California, San Francisco, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Luks","sequence":"additional","affiliation":[{"name":"11Department of Radiology and Biomedical Imaging, University of California, San Francisco, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalan","family":"Zhang","sequence":"additional","affiliation":[{"name":"6Department of Neurological Surgery, University of California, San Francisco, California."},{"name":"12Department of Epidemiology and Biostatistics, University of California, San Francisco, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhuri","family":"Kambhampati","sequence":"additional","affiliation":[{"name":"4Center for Genetic Medicine Research, Children's National Hospital, Washington, DC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[{"name":"13Department of Neurology, University of California, San Francisco, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sridevi","family":"Yadavilli","sequence":"additional","affiliation":[{"name":"4Center for Genetic Medicine Research, Children's National Hospital, Washington, DC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[{"name":"2Division of Neurosurgery, Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0838-2405","authenticated-orcid":false,"given":"Krutika S.","family":"Gaonkar","sequence":"additional","affiliation":[{"name":"2Division of Neurosurgery, Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania."},{"name":"14Department of Bioinformatics and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2171-3627","authenticated-orcid":false,"given":"Jo Lynne","family":"Rokita","sequence":"additional","affiliation":[{"name":"2Division of Neurosurgery, Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania."},{"name":"14Department of Bioinformatics and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8526-5694","authenticated-orcid":false,"given":"Adam","family":"Kraya","sequence":"additional","affiliation":[{"name":"2Division of Neurosurgery, Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7359-8643","authenticated-orcid":false,"given":"John","family":"Kuhn","sequence":"additional","affiliation":[{"name":"15College of Pharmacy, University of Texas Health Science Center, San Antonio, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winnie","family":"Liang","sequence":"additional","affiliation":[{"name":"16Translational Genomic Research Institute (TGEN), Phoenix, Arizona."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0093-0374","authenticated-orcid":false,"given":"Sara","family":"Byron","sequence":"additional","affiliation":[{"name":"16Translational Genomic Research Institute (TGEN), Phoenix, Arizona."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3382-6787","authenticated-orcid":false,"given":"Michael","family":"Berens","sequence":"additional","affiliation":[{"name":"16Translational Genomic Research Institute (TGEN), Phoenix, Arizona."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Molinaro","sequence":"additional","affiliation":[{"name":"6Department of Neurological Surgery, University of California, San Francisco, California."},{"name":"12Department of Epidemiology and Biostatistics, University of California, San Francisco, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9630-2075","authenticated-orcid":false,"given":"Michael","family":"Prados","sequence":"additional","affiliation":[{"name":"6Department of Neurological Surgery, University of California, San Francisco, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0436-4189","authenticated-orcid":false,"given":"Adam","family":"Resnick","sequence":"additional","affiliation":[{"name":"2Division of Neurosurgery, Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3042-9521","authenticated-orcid":false,"given":"Sebastian M.","family":"Waszak","sequence":"additional","affiliation":[{"name":"13Department of Neurology, University of California, San Francisco, California."},{"name":"17Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo and Oslo University Hospital, Oslo, Norway."},{"name":"18Division of Pediatric and Adolescent Medicine, Department of Pediatric Research, Rikshospitalet, Oslo University Hospital, Oslo, Norway."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Nazarian","sequence":"additional","affiliation":[{"name":"4Center for Genetic Medicine Research, Children's National Hospital, Washington, DC."},{"name":"5Institute for Biomedical Sciences, The George Washington University School of Medicine and Health Sciences, Washington, DC."},{"name":"19Department of Oncology, University Children's Hospital Z\u00fcrich, Z\u00fcrich, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3452-5150","authenticated-orcid":false,"given":"Sabine","family":"Mueller","sequence":"additional","affiliation":[{"name":"6Department of Neurological Surgery, University of California, San Francisco, California."},{"name":"9Department of Pediatrics, University of California, San Francisco, California."},{"name":"13Department of Neurology, University of California, San Francisco, California."},{"name":"19Department of Oncology, University Children's Hospital Z\u00fcrich, Z\u00fcrich, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2022,7,19]]},"reference":[{"key":"2025112507145800100_bib1","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/neuonc\/noq205","article-title":"Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group","volume":"13","author":"Cohen","year":"2011","journal-title":"Neuro Oncol"},{"key":"2025112507145800100_bib2","article-title":"A pediatric trial of radiation\/cetuximab followed by irinotecan\/cetuximab in newly diagnosed diffuse pontine gliomas and high-grade astrocytomas: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium study","author":"Macy","journal-title":"Pediatr Blood Cancer"},{"key":"2025112507145800100_bib3","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3389\/fonc.2015.00237","article-title":"DIPG in Children\u2014What Can We Learn from the Past?","volume":"5","author":"Vanan","year":"2015","journal-title":"Front Oncol"},{"key":"2025112507145800100_bib4","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11060-017-2575-9","article-title":"A phase I\/II study of gemcitabine during radiotherapy in children with newly diagnosed diffuse intrinsic pontine glioma","volume":"135","author":"Veldhuijzen van Zanten","year":"2017","journal-title":"J Neurooncol"},{"key":"2025112507145800100_bib5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1586\/14737140.2015.974563","article-title":"A twenty-year review of diagnosing and treating children with diffuse intrinsic pontine glioma in the Netherlands","volume":"15","author":"Veldhuijzen van Zanten","year":"2015","journal-title":"Expert Rev Anticancer Ther"},{"key":"2025112507145800100_bib6","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S1470-2045(18)30322-X","article-title":"Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial","volume":"19","author":"Souweidane","year":"2018","journal-title":"Lancet Oncol"},{"key":"2025112507145800100_bib7","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/ng.2950","article-title":"Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma","volume":"46","author":"Fontebasso","year":"2014","journal-title":"Nat Genet"},{"key":"2025112507145800100_bib8","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00401-012-0998-0","article-title":"K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas","volume":"124","author":"Khuong-Quang","year":"2012","journal-title":"Acta Neuropathol"},{"key":"2025112507145800100_bib9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/ng.1102","article-title":"Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas","volume":"44","author":"Wu","year":"2012","journal-title":"Nat Genet"},{"key":"2025112507145800100_bib10","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/ng.2936","article-title":"Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations","volume":"46","author":"Buczkowicz","year":"2014","journal-title":"Nat Genet"},{"key":"2025112507145800100_bib11","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1101\/gad.217778.113","article-title":"The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression","volume":"27","author":"Chan","year":"2013","journal-title":"Genes Dev"},{"key":"2025112507145800100_bib12","first-page":"153","article-title":"Pediatric high-grade glioma: biologically and clinically in need of new thinking","volume":"19","author":"Jones","year":"2017","journal-title":"Neuro Oncol"},{"key":"2025112507145800100_bib13","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ccell.2017.08.017","article-title":"Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma","volume":"32","author":"Mackay","year":"2017","journal-title":"Cancer Cell"},{"key":"2025112507145800100_bib14","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/neuonc\/nos067","article-title":"Insights into pediatric diffuse intrinsic pontine glioma through proteomic analysis of cerebrospinal fluid","volume":"14","author":"Saratsis","year":"2012","journal-title":"Neuro Oncol"},{"key":"2025112507145800100_bib15","doi-asserted-by":"crossref","first-page":"12141","DOI":"10.18632\/oncotarget.3716","article-title":"The emerging role of NG2 in pediatric diffuse intrinsic pontine glioma","volume":"6","author":"Yadavilli","year":"2015","journal-title":"Oncotarget"},{"key":"2025112507145800100_bib16","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.molcel.2019.08.030","article-title":"Histone variant and cell context determine H3K27M Reprogramming of the enhancer landscape and oncogenic State","volume":"76","author":"Nagaraja","year":"2019","journal-title":"Mol Cell"},{"key":"2025112507145800100_bib17","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/ng.2925","article-title":"Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma","volume":"46","author":"Taylor","year":"2014","journal-title":"Nat Genet"},{"key":"2025112507145800100_bib18","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1158\/0008-5472.CAN-14-1298","article-title":"ACVR1 mutations in DIPG: lessons learned from FOP","volume":"74","author":"Taylor","year":"2014","journal-title":"Cancer Res"},{"key":"2025112507145800100_bib19","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO Classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"key":"2025112507145800100_bib20","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1002\/ijc.32258","article-title":"A pilot precision medicine trial for children with diffuse intrinsic pontine glioma-PNOC003: a report from the Pacific Pediatric Neuro-Oncology Consortium","volume":"145","author":"Mueller","year":"2019","journal-title":"Int J Cancer"},{"key":"2025112507145800100_bib21","doi-asserted-by":"crossref","first-page":"6325","DOI":"10.1172\/JCI140378","article-title":"Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma","volume":"130","author":"Mueller","year":"2020","journal-title":"J Clin Invest"},{"key":"2025112507145800100_bib22","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/neuonc\/noy070","article-title":"Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine glioma","volume":"20","author":"Gupta","year":"2018","journal-title":"Neuro Oncol"},{"key":"2025112507145800100_bib23","first-page":"56","article-title":"An integrated framework for reporting clinically relevant biomarkers from paired tumor\/normal genomic and transcriptomic sequencing data in support of clinical trials in personalized medicine","author":"Nasser","year":"2015","journal-title":"Pac Symp Biocomput"},{"key":"2025112507145800100_bib24","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1158\/1078-0432.CCR-17-0963","article-title":"Prospective feasibility trial for genomics-informed treatment in recurrent and progressive glioblastoma","volume":"24","author":"Byron","year":"2018","journal-title":"Clin Cancer Res"},{"key":"2025112507145800100_bib25","doi-asserted-by":"crossref","first-page":"5850","DOI":"10.1158\/1078-0432.CCR-18-1345","article-title":"Clinically relevant and minimally invasive tumor surveillance of pediatric diffuse midline gliomas using patient-derived liquid biopsy","volume":"24","author":"Panditharatna","year":"2018","journal-title":"Clin Cancer Res"},{"key":"2025112507145800100_bib26","doi-asserted-by":"crossref","DOI":"10.3791\/59721","article-title":"Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids","author":"Bonner","year":"2019","journal-title":"J Vis Exp"},{"key":"2025112507145800100_bib27","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1200\/JCO.2015.62.2290","article-title":"WEE1 Kinase as a target for cancer therapy","volume":"33","author":"Mueller","year":"2015","journal-title":"Journal Clin Oncol"},{"key":"2025112507145800100_bib28","article-title":"An open pediatric brain tumor atlas","author":"Shapiro","year":"2022"},{"key":"2025112507145800100_bib29","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.cell.2017.09.042","article-title":"Universal patterns of selection in cancer and somatic tissues","volume":"171","author":"Martincorena","year":"2017","journal-title":"Cell"},{"key":"2025112507145800100_bib30","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41568-020-0290-x","article-title":"A compendium of mutational cancer driver genes","volume":"20","author":"Martinez-Jimenez","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"2025112507145800100_bib31","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature26000","article-title":"DNA methylation-based classification of central nervous system tumours","volume":"555","author":"Capper","year":"2018","journal-title":"Nature"},{"key":"2025112507145800100_bib32","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nm.3855","article-title":"Functionally defined therapeutic targets in diffuse intrinsic pontine glioma","volume":"21","author":"Grasso","year":"2015","journal-title":"Nat Med"},{"key":"2025112507145800100_bib33","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1007\/s00432-013-1539-5","article-title":"Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer","volume":"139","author":"Nygren","year":"2013","journal-title":"J Cancer Res Clin Oncol"},{"key":"2025112507145800100_bib34","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3109\/0284186X.2013.844359","article-title":"Drug repositioning from bench to bedside: tumour remission by the antihelmintic drug mebendazole in refractory metastatic colon cancer","volume":"53","author":"Nygren","year":"2014","journal-title":"Acta Oncol"},{"key":"2025112507145800100_bib35","first-page":"7163","article-title":"Everolimus inhibits breast cancer cell growth through PI3K\/AKT\/mTOR signaling pathway","volume":"17","author":"Du","year":"2018","journal-title":"Mol Med Rep"},{"key":"2025112507145800100_bib36","doi-asserted-by":"crossref","first-page":"101960","DOI":"10.1016\/j.jchemneu.2021.101960","article-title":"Everolimus inhibits PI3K\/Akt\/mTOR and NF-kB\/IL-6 signaling and protects seizure-induced brain injury in rats","volume":"114","author":"Huang","year":"2021","journal-title":"J Chem Neuroanat"},{"key":"2025112507145800100_bib37","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1093\/neuonc\/noaa071","article-title":"A phase II study of continuous oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1-associated pediatric low-grade glioma: a Neurofibromatosis Clinical Trials Consortium study","volume":"22","author":"Ullrich","year":"2020","journal-title":"Neuro Oncol"},{"key":"2025112507145800100_bib38","doi-asserted-by":"crossref","first-page":"6788","DOI":"10.1158\/1078-0432.CCR-19-0126","article-title":"TP53 Pathway alterations drive radioresistance in diffuse intrinsic pontine gliomas (DIPG)","volume":"25","author":"Werbrouck","year":"2019","journal-title":"Clin Cancer Res"},{"key":"2025112507145800100_bib39","doi-asserted-by":"crossref","first-page":"a026096","DOI":"10.1101\/cshperspect.a026096","article-title":"Genome stability requires p53","volume":"6","author":"Eischen","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2025112507145800100_bib40","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2011.12.013","article-title":"Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations","volume":"148","author":"Rausch","year":"2012","journal-title":"Cell"},{"key":"2025112507145800100_bib41","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature25480","article-title":"The landscape of genomic alterations across childhood cancers","volume":"555","author":"Grobner","year":"2018","journal-title":"Nature"},{"key":"2025112507145800100_bib42","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"key":"2025112507145800100_bib43","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1038\/ncomms3126","article-title":"Evaluating cell lines as tumour models by comparison of genomic profiles","volume":"4","author":"Domcke","year":"2013","journal-title":"Nat Commun"},{"key":"2025112507145800100_bib44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/1541-7786.MCR-15-0189","article-title":"Tumor-derived cell lines as molecular models of cancer pharmacogenomics","volume":"14","author":"Goodspeed","year":"2016","journal-title":"Mol Cancer Res"},{"key":"2025112507145800100_bib45","doi-asserted-by":"crossref","first-page":"629","DOI":"10.14694\/EdBook_AM.2012.32.59","article-title":"Is biopsy safe in children with newly diagnosed diffuse intrinsic pontine glioma?","author":"Puget","year":"2012","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"2025112507145800100_bib46","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1007\/s00381-015-2832-1","article-title":"Biopsy in a series of 130 pediatric diffuse intrinsic Pontine gliomas","volume":"31","author":"Puget","year":"2015","journal-title":"Childs Nerv Syst"},{"key":"2025112507145800100_bib47","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3171\/2017.2.PEDS1665","article-title":"Update on the diagnostic value and safety of stereotactic biopsy for pediatric brainstem tumors: a systematic review and meta-analysis of 735 cases","volume":"20","author":"Hamisch","year":"2017","journal-title":"J Neurosurg Pediatr"},{"key":"2025112507145800100_bib48","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11060-017-2708-1","article-title":"Development of the CNS TAP tool for the selection of precision medicine therapies in neuro-oncology","volume":"137","author":"Linzey","year":"2018","journal-title":"J Neurooncol"},{"key":"2025112507145800100_bib49","doi-asserted-by":"crossref","first-page":"vi195","DOI":"10.1093\/neuonc\/noz175.812","article-title":"PDTM-36. Whole-exome sequencing (WES) of DIPG patients from the biomede trial reveals new prognostic subgroups with specific oncogenic programmes","volume":"21","author":"Debily","year":"2019","journal-title":"Neuro Oncol"},{"key":"2025112507145800100_bib50","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40478-017-0436-6","article-title":"Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma","volume":"5","author":"Huang","year":"2017","journal-title":"Acta Neuropathol Commun"}],"container-title":["Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article-pdf\/doi\/10.1158\/1078-0432.CCR-22-0803\/3180773\/ccr-22-0803.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article-pdf\/doi\/10.1158\/1078-0432.CCR-22-0803\/3187755\/ccr-22-0803.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article-pdf\/28\/18\/3965\/3205618\/3965.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article-pdf\/28\/18\/3965\/3205618\/3965.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T12:15:08Z","timestamp":1764072908000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article\/28\/18\/3965\/708985\/Upfront-Biology-Guided-Therapy-in-Diffuse"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,19]]},"references-count":50,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2022,7,19]]},"published-print":{"date-parts":[[2022,9,15]]}},"URL":"https:\/\/doi.org\/10.1158\/1078-0432.ccr-22-0803","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/1078-0432.22486325","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22486337","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22486325.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22486316","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22486328","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22486322","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22486334.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22486334","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22486331.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22486340.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22486319.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22486319","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22486316.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22486337.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22486340","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22486322.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22486331","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22486328.v1","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/1078-0432.c.6532295","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.c.6532295.v1","asserted-by":"object"}]},"ISSN":["1078-0432","1557-3265"],"issn-type":[{"value":"1078-0432","type":"print"},{"value":"1557-3265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,19]]}}}